» Articles » PMID: 34349746

Stage-Dependent Within-Individual Comparison Reveals SIV-Specific Activation/Exhaustion Shift in Rhesus Macaques

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2021 Aug 5
PMID 34349746
Authors
Affiliations
Soon will be listed here.
Abstract

It is challenging to trace the complicated individual-based variations of HIV-specific immunocompetence shift during the successful antiretroviral therapy (ART) era. Using eight rhesus monkeys simulating a longitudinal stage-dependent cohort (baseline-SIV acute infection-SIV suppression by ART-ART withdrawal), baseline immunocompetence monitoring for 28 days (SIV-negative stage, SN) was compared with host immunocompetence undergoing 90-day ART treatment (SIV-suppressed stage, SS) to reveal the SIV-specific immunity shift aroused by undetectable individual viral replication. During acute SIV infection for 98 days (SIV-emerged stage, SE), immune activation was compared with re-immune activation post ART for 49-day follow-up (SIV-rebounded stage, SR) to reveal the SIV-specific immune activation variation aroused by detectable individual viral replication. Individual immunocompetence was measured by co-expression of CD4, CD8, CD38, HLA-DR, CCR7, CD45RA, and PD-1 on T cells and a cytokine panel. Compared with SN, mild immune activation/exhaustion was characterized by increased CD38 HLA-DR CD4/CD8 T-cell subsets and PD-1 memory CD4/CD8 T-cell subsets with three elevated cytokines (MIP-1β, IL-8, and IL-10) significantly emerged in SS. Compared with SE, SR produced more exhaustion characterized by increased PD-1 CD4 T cells and decreased PD-1 CD4 T cells with four elevated pro-inflammatory cytokines (IFN-γ, IL-1β, IL-6, and TNF-α). By such individualized stage-dependent comparison, the sustainable immune activation was found from activation/exhaustion shifted into exhaustion during the longitudinal viral persistence. Further, validated SIV accelerates host immunosenescence continuously independent of viral replication.

References
1.
Hansen S, Vieville C, Whizin N, Coyne-Johnson L, Siess D, Drummond D . Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med. 2009; 15(3):293-9. PMC: 2720091. DOI: 10.1038/nm.1935. View

2.
Robbins G, Spritzler J, Chan E, Asmuth D, Gandhi R, Rodriguez B . Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis. 2009; 48(3):350-61. PMC: 2676920. DOI: 10.1086/595888. View

3.
Goepfert P, Bansal A, Edwards B, Ritter Jr G, Tellez I, McPherson S . A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J Virol. 2000; 74(21):10249-55. PMC: 102068. DOI: 10.1128/jvi.74.21.10249-10255.2000. View

4.
van der Most R, Murali-Krishna K, Lanier J, Wherry E, Puglielli M, Blattman J . Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology. 2003; 315(1):93-102. DOI: 10.1016/j.virol.2003.07.001. View

5.
van den Dries L, Claassen M, Groothuismink Z, van Gorp E, Boonstra A . Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls. Virology. 2017; 509:133-139. DOI: 10.1016/j.virol.2017.06.014. View